Europium-labeled oligonucleotides to detect point mutations: application to PI Z α1-antitrypsin deficiency

15Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We describe a novel assay for detection of point mutations. The method combines the specificity and sensitivity of the polymerase chain reaction (PCR) and allele-specific oligonucleotides (ASO) with highly sensitive time-resolved fluorometry. ASO probes differing by a single base substitution and labeled with europium (Eu) chelates were hybridized in solution simultaneously with a biotinylated oligomer to a PCR-amplified nucleic acid fragment. The hybrids formed were then collected onto streptavidincoated microtitration wells. Subsequently, the hybrids were washed under stringent conditions and the remaining ASO probe was measured in a time-resolved fluorometer. We discuss the strategy underlying the design of the Eu-labeled ASO probes for the solution hybridization assay. The method was applied to the detection of the Z-mutation in the α1-antitrypsin gene. Evaluation of whole-blood samples spotted on Guthrie cards demonstrated successful accuracy of the method.

Cite

CITATION STYLE

APA

Dahlén, P., Carlson, J., Liukkonen, L., Lilja, H., Siitari, H., Hurskainen, P., … Lövgren, T. (1993). Europium-labeled oligonucleotides to detect point mutations: application to PI Z α1-antitrypsin deficiency. Clinical Chemistry, 39(8), 1626–1631. https://doi.org/10.1093/clinchem/39.8.1626

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free